TOIIWThe Oncology Institute Inc. Warrant
0.0500USD+2.25%Mkt Cap: —P/E: —25d ago
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The compa…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)545.76M $
Gross Profit76.44M $
Net Income (TTM)-60.61M $
Revenue/Share5.537 USD
Last Price0.0500 USD
Fiscal Year End—
MR Quarter—
Employees641
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)-602.09
EPS (Forward)—
52W Range
0.026055% of range0.0698
52W High0.0698 USD
52W Low0.0260 USD
Profitability
Gross Margin15.20%
Oper. Margin-4.42%
EBITDA Margin-4.75%
Profit Margin-12.06%
ROE385.53%
ROA-36.81%
Growth
Revenue Growth41.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.59M $
CapEx (TTM)3.20M $
FCF Margin-2.81%
FCF Yield—
Net Debt74.63M $
Net Debt/EBITDA-2.88
Balance Sheet
Debt/Equity-6.60
Current Ratio1.47
Quick Ratio1.13
Book Value/Sh-0.1630 USD
Cash/Share0.3030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float86.67M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta0.42
S&P 52W Chg18.16%
Avg Vol (30d)9.67K
Avg Vol (10d)—
Technical Indicators
RSI (14)49.1
MACD-0.0001
MACD Signal-0.0001
MACD Hist.-0.0000
BB Upper0.0689 USD
BB Middle0.0497 USD
BB Lower0.0305 USD
BB Width77.30%
ATR (14)0.0071 USD
Vol Ratio (20d)0.11x